Xeris Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XERS and other ETFs, options, and stocks.About XERS
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev.
XERS Key Statistics
Stock Snapshot
The current Xeris Biopharma(XERS) stock price is $6.28, with a market capitalization of 1.08B. The stock trades at a price-to-earnings (P/E) ratio of 93.74.
On 2026-05-12, Xeris Biopharma(XERS) stock moved within a range of $6.10 to $6.34. With shares now at $6.28, the stock is trading +2.9% above its intraday low and -0.9% below the session's peak.
Trading activity shows a volume of 338.93K, compared to an average daily volume of 2.07M.
Over the past 52 weeks, Xeris Biopharma(XERS) stock has traded between a high of $10.08 and a low of $4.30.
Over the past 52 weeks, Xeris Biopharma(XERS) stock has traded between a high of $10.08 and a low of $4.30.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.